SAFETY ISSUES IN THE TREATMENT OF PATIENTS TAKING DABIGATRAN 由 E. S. Kropacheva

獲取全文

SAFETY OF THERAPY AND PATRONAGE SYSTEM IN PATIENTS WHO RECEIVE WARFARIN 由 E. S. Kropacheva

獲取全文

Intracardiac thrombosis: frequency, risk factors and place of oral anticoagulants in treatment 由 E. S. Kropacheva

獲取全文

SAFETY OF LONGTERM THERAPY WITH WARFARIN: POSSIBILITY OF TREATMENT RENEWING AFTER HEMORRHAGIC COMPLICATIONS 由 E. S. Kropacheva

獲取全文

SELECTING AN OPTIMAL LONG-TERM ANTICOAGULANT THERAPY FOR A PATIENT WITH ATRIAL FIBRILLATION AND RECURRENT MINOR HEMORRHAGE. CLINICAL FOLLOW-UP 由 E. S. Kropacheva, E. P. Panchenko

獲取全文

The place of dabigatran in the treatment of patients with atrial fibrillation in the light of modern recommendations 由 E. S. Kropacheva, E. P. Panchenko

獲取全文

Aspects of anticoagulant therapy in patients with atrial fibrillation in the light of updated guidelines of the European society of cardiology 2020: the position of dabigatran 由 E. S. Kropacheva, E. P. Panchenko

獲取全文

ASPECTS OF MULTICOMPONENT THERAPY AND PERIOPERATIVE TACTICS IN A PATIENT WITH ATRIAL FIBRILLATION RECEIVING RIVAROXABAN THERAPY. CLINICAL OBSERVATION 由 O. A. Zemlyanskaya, E. S. Kropacheva

獲取全文

Rivaroxaban in patients with atrial fibrillation: from research to real practice (based on REGistry of Long-term AnTithrombotic TherApy-2 (REGATA)) 由 E. S. Kropacheva, E. N. Krivosheeva, E. P. Panchenko

獲取全文

CLINICAL FACTORS AND ANTICOAGULATION LEVEL THAT DETERMINE THE SUDDEN LOSS OF KIDNEY FUNCTION IN PATIENTS LONG-TAKING WARFARIN (A 5-YEAR PROSPECTIVE, OBSERVATIONAL STUDY) 由 E. S. Kropacheva, O. A. Zemlyanskaya, A. В. Dobrovolsky, Е. P. Panchenko

獲取全文

THE EFFICACY OF LONG-TERM WARFARIN THERAPY: THE IMPACT ON THE INCIDENCE OF ISCHEMIC CEREBROVASCULAR DISORDERS AND CLINICAL PREDICTORS OF DEVELOPING SUCH DISORDERS. (Results of a pr... 由 E. S. KROPACHEVA, O. A. ZEMLYANSKAYA, A. B. DOBROVOLSKY, E. P. PANCHENKO

獲取全文

Need to determine the residual concentrations of direct oral anticoagulants in patients with atrial fibrillation undergoing transcatheter implantation of the aortic valve 由 A. I. Staroverova, E. S. Kropacheva, A. B. Dobrovolsky, E. V. Titaeva, E. P. Panchenko

獲取全文

SAFETY OF LONG-TERM THERAPY WITH WARFARIN: HEMORRHAGE FREQUENCY AND CLINICAL PREDICTORS (results of a prospective 15-year follow-up) 由 E. S. Kropacheva, O. A. Zemlyanskaya, E. P. Panchenko, A. B. Dobrovolsky, E. N. Krivosheeva

獲取全文

Modern possibilities and prospects in evaluating the anticoagulant effect of direct oral anticoagulants 由 A. I. Mironova, E. S. Kropacheva, A. B. Dobrovolsky, E. V. Titaeva, E. P. Panchenko

獲取全文

Growth differentiation factor 15 and the risk of cardiovascular events in patients with atrial fibrillation after elective percutaneous coronary intervention 由 E. N. Krivosheeva, E. S. Kropacheva, A. B. Dobrovolsky, E. V. Titaeva, E. P. Panchenko

獲取全文

EURASIAN CLINICAL RECOMMENDATIONS ON DIAGNOSIS AND TREATMENT OF ATRIAL FIBRILLATION 由 S. P. Golitsyn, E. P. Panchenko, E. S. Kropacheva, L. Yu. Layovich, E. B. Maikov, N. Yu. Mironov, O. O. Shakhmatova

獲取全文

2020 Clinical guidelines for Atrial fibrillation and atrial flutter 由 M. G. Arakelyan, L. A. Bockeria, E. Yu. Vasilieva, S. P. Golitsyn, E. Z. Golukhova, M. V. Gorev, K. V. Davtyan, O. M. Drapkina, E. S. Kropacheva, E. A. Kuchinskaya, L. Yu. Lajovich, N. Yu. Mironov, I. E. Mishina, E. P. Panchenko, A. Sh. Revishvili, F. G. Rzayev, B. A. Tatarsky, M. D. Utsumueva, O. O. Shakhmatova, N. B. Shlevkov, A. V. Shpektor, D. A. Andreev, E. A. Artyukhina, O. L. Barbarash, A. S. Galyavich, D. V. Duplyakov, S. A. Zenin, D. S. Lebedev, E. N. Mikhailov, N. A. Novikova, S. V. Popov, A. G. Filatov, E. V. Shlyakhto, Yu. V. Shubik

獲取全文